Blow For Sandoz And Boehringer As PBM OptumRx Deletes Humira Biosimilars
Amgen’s Amjevita Will Remain As Tier Two Product; Humira Brand Is Tier Three
A pair of Humira biosimilars, including one from Sandoz, will no longer be covered on one of OptumRx’s 2025 US commercial formularies.
